A rigorous evaluation of optimal peptide targets for MS-based clinical diagnostics of Coronavirus Disease 2019 (COVID-19).

Mostrar otras versiones (1)

The Coronavirus Disease 2019 (COVID-19) global pandemic has had a profound, lasting impact on the world’s population. A key aspect to providing care for those with COVID-19 and checking its further spread is early and accurate diagnosis of infection, which has been generally done via methods for amp...

Descripción completa

Detalles Bibliográficos
Autores principales: Rajczewski, Andrew T., Mehta, Subina, Nguyen, Dinh Duy An, Grüning, Björn A., Johnson, James E., McGowan, Thomas, Griffin, Timothy J., Jagtap, Pratik D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941646/
https://www.ncbi.nlm.nih.gov/pubmed/33688669
http://dx.doi.org/10.1101/2021.02.09.21251427

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7941646/
https://www.ncbi.nlm.nih.gov/pubmed/33688669
http://dx.doi.org/10.1101/2021.02.09.21251427

Ejemplares similares